FDA approves nonprofit's over-the-counter opioid overdose nasal spray

ViewThe U.S. Food and Drug Administration approved another over-the-counter naloxone nasal spray used to reverse opioid overdose on Friday.

RiVive, made by Harm Reduction Therapeutics, is the second nonprescription naloxone product the FDA has approved. But unlike other opioid overdose products, the 3 milligram treatment...